David Winkel
Papers
4
Total Citations
39
H-Index
4
About
David Winkel is a leading researcher in the field of urologic oncology, with a primary focus on advancing the precision and safety of prostate cancer diagnostics. His work centers on the clinical implementation and optimization of robotic-assisted transperineal MRI-US fusion-guided prostate biopsy, a novel technique designed to improve the detection of clinically significant cancer while minimizing invasiveness. Winkel’s major contributions include a landmark prospective study demonstrating the high diagnostic accuracy of robotic-assisted target saturation biopsy, which directly addresses the challenge of intralesional tumor heterogeneity—a key limitation of standard sampling methods. His research has also been pivotal in characterizing the learning curve for this robotic platform, showing that automation can flatten the trajectory for new adopters, and in establishing a strong safety profile for the procedure, with studies documenting excellent patient tolerability and minimal impact on erectile function. With his most cited work accumulating over 17 citations and his recent 2024 publication already garnering significant attention, Winkel is shaping the future of targeted, patient-friendly prostate cancer diagnosis.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4